Why is Hester Bios falling/rising?

As of 24-Sep, Hester Biosciences Ltd is currently priced at 1,959.00, reflecting a decrease of 14.0 points or 0.71%. The stock has been underperforming, having fallen for the last six consecutive days, resulting in a total decline of 5% during this period. In terms of returns, the stock has decreased by 4.44% over the past week and 2.97% over the past month, while it has experienced a significant year-to-date decline of 18.12%. Despite these negative movements, the company has shown strong financial performance, with a net profit growth of 145.1% and positive results for the last five consecutive quarters, which may indicate underlying strength that could support the stock in the long term.
Broader market context shows that the Sensex has only declined by 1.18% over the past week, indicating that Hester Biosciences Ltd is underperforming relative to the broader market. While the stock's recent performance has been negative, the increase in investor participation, as evidenced by a rise in delivery volume, suggests some level of interest despite the price drop. The liquidity of the stock remains adequate for trading, which may provide opportunities for recovery if market sentiment shifts positively. Overall, while the stock is currently facing downward pressure, its strong financial fundamentals could play a crucial role in its future performance.